Susanne M. Hooshmand

<i>O</i> 6-Methylguanine DNA Methyltransferase Deficiency and Response to Temozolomide-Based Therapy in Patients with Neuroendocrine Tumors

Matthew H. Kulke, Jason L. Hornick, Christine Frauenhoffer et al. · Clinical Cancer Research · 2008 · 380 citations · Full text

Medicine, Oncology, Chemotherapy +16

Somatic mutation of CDKN1B in small intestine neuroendocrine tumors

Joshua M. Francis, Adam Kieżun, Alex H. Ramos et al. · Nature Genetics · 2013 · 373 citations · Full text

Medicine, Oncology, Pathology +13

Prognostic and predictive value of common mutations for treatment response and survival in patients with metastatic colorectal cancer

John Souglakos, Juliet Philips, R Wang et al. · British Journal of Cancer · 2009 · 320 citations · Full text

Medicine, Genetics, Oncology +17

Clinical presentation, recurrence, and survival in patients with neuroendocrine tumors: results from a prospective institutional database

Monica Ter‐Minassian, Jennifer A. Chan, Susanne M. Hooshmand et al. · Endocrine Related Cancer · 2013 · 130 citations · Full text

Medicine, Oncology, Surgery +17

Prognostic Significance of MTOR Pathway Component Expression in Neuroendocrine Tumors

Zhi Rong Qian, Monica Ter‐Minassian, Jennifer A. Chan et al. · Journal of Clinical Oncology · 2013 · 117 citations · Full text

Medicine, Cancer Biology, Oncology +17